Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recurrence
×
Lenalidomide
×
Dermatologic
×
Clear all
Filters
3
NCT03302728
2022-05-19
EpiBrentlen
Peter MacCallum Cancer Centre, Australia
Phase 1
Completed
6 enrolled